Literature DB >> 10448968

Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120.

M Ferrer1, B J Sullivan, K L Godbout, E Burke, H S Stump, J Godoy, A Golden, A T Profy, M R van Schravendijk.   

Abstract

Through an integrated study of the reactivity of a monoclonal antibody, 803-15.6, with synthetic peptides and native recombinant HIV-1 envelope glycoprotein gp120, we have obtained structure-functional information on a region of rgp120 not yet elucidated by X-ray crystallography. mAb 803-15.6 binds with high affinity and broad cross-clade specificity to the conserved C-terminal region (amino acids 502-516) of HIV-1 rgp120. Phage display selection from a random peptide library identified the core binding motif as AXXKXRH, homologous to residues 502-508. Using quantitative binding analyses, the affinity of mAb 803-15.6 for native, monomeric recombinant gp120HXB2 (rgp120) was found to be similar to that for the synthetic gp120 peptide (502-516). Circular dichroism studies indicate that the synthetic peptide largely has a random coil conformation in solution. The results therefore suggest that the 803-15.6 epitope is fully accessible on rgp120 and that this region of rgp120 is as flexible as the synthetic peptide. Residues 502-504 are on the edge of a putative gp41 binding site that has been postulated to change conformation on CD4 binding. However, the affinity of mAb 803-15.6 for rgp120 is not affected by binding of CD4 and vice-versa. These results suggest either that the 502-504 region does not change conformation upon CD4 binding, or that recombinant gp120 does not undergo the same changes as occur in the native viral gp120-gp41 oligomer. The detailed characterization of the 803-15.6 epitope may be useful for further study of the role of the C5 region of gp120 in the viral attachment and fusion process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448968     DOI: 10.1034/j.1399-3011.1999.00082.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  7 in total

1.  Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology.

Authors:  Ying Gu; Jun Zhang; Ying-Bing Wang; Shao-Wei Li; Hai-Jie Yang; Wen-Xin Luo; Ning-Shao Xia
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

Review 2.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

3.  Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries.

Authors:  M Ferrer; S C Harrison
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein.

Authors:  Gregory P Owens; Andrew J Shearer; Xiaoli Yu; Alanna M Ritchie; Kathryne M Keays; Jeffrey L Bennett; Donald H Gilden; Mark P Burgoon
Journal:  J Virol       Date:  2006-12       Impact factor: 5.103

5.  Activation of the Akt-CREB signalling axis by a proline-rich heptapeptide confers resistance to stress-induced cell death and inflammation.

Authors:  Johannes Herkel; Jörg Schrader; Neta Erez; Ansgar W Lohse; Irun R Cohen
Journal:  Immunology       Date:  2017-05-16       Impact factor: 7.397

6.  Identification of measles virus epitopes using an ultra-fast method of panning phage-displayed random peptide libraries.

Authors:  Xiaoli Yu; Olga Barmina; Mark Burgoon; Don Gilden
Journal:  J Virol Methods       Date:  2009-01-03       Impact factor: 2.014

Review 7.  Phages and HIV-1: from display to interplay.

Authors:  Sylvie Delhalle; Jean-Claude Schmit; Andy Chevigné
Journal:  Int J Mol Sci       Date:  2012-04-13       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.